The evidence of association between BRCA1 mutations and PCa risk is inconsistent, with reported RRs in the range 0.3–4 [3], [5], [7], [8], [9], [10], [12], [13], [16], [17], [18], [19], [20]. This evidence concerns the gene BRCA1 and posterior cortical atrophy.